Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Natural Capsules's
Operating Income
for the
three
months ended in Mar. 2026 was ₹-30 Mil. Natural Capsules's Interest Expense for the
three
months ended in Mar. 2026 was ₹-29 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Natural Capsules's Interest Coverage or its related term are showing as below:
BOM:524654's Interest Coverage is not ranked *
in the Drug Manufacturers industry.
Industry Median: 12.82 * Ranked among companies with meaningful Interest Coverage only.
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Natural Capsules Interest Coverage Related Terms
Natural Capsules Interest Coverage Historical Data
* Premium members only.
The historical data trend for Natural Capsules's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Drug Manufacturers - Specialty & Generic subindustry, Natural Capsules's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Natural Capsules Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Natural Capsules's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Natural Capsules's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Natural Capsules did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Natural Capsules (BOM:524654) has a Interest Coverage of 0 (At Loss) as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Natural Capsules and its competitors. According to the industry distribution chart, Natural Capsules ranks #999999 out of 684 companies in the Drug Manufacturers industry.
Is Natural Capsules' Interest Coverage too high?
Natural Capsules' current Interest Coverage is 0 (At Loss). Based on the distribution chart, Natural Capsules ranks #999999 out of 684 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Natural Capsules has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Natural Capsules' Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Natural Capsules ranks #999999 out of 684 companies for Interest Coverage. This places Natural Capsules in the lower half of its industry. The industry median Interest Coverage is 12.82. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.82, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Natural Capsules and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Natural Capsules's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Natural Capsules stock overvalued right now?
Based on GuruFocus' analysis, Natural Capsules (BOM:524654) is currently considered Possible Value Trap. The stock's GF Value™ is ₹313.68, compared to a current price of ₹155.80 — trading 50.3% below its estimated fair value. The current Interest Coverage is 0 (At Loss). Natural Capsules' overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Natural Capsules (BOM:524654), the current Interest Coverage is 0 (At Loss) as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Natural Capsules (BOM:524654) Overvalued in 2026?
Based on GuruFocus' analysis, Natural Capsules stock appears to be undervalued.
The current stock price of ₹155.80 is trading 50.3% below its estimated GF Value™ of ₹313.68.
GuruFocus considers Natural Capsules to be Possible Value Trap.
Key valuation signals for BOM:524654:
Interest Coverage: 0 (At Loss)
GF Value™: ₹313.68 vs. price of ₹155.80 (50.3% below fair value)
No single metric tells the full story. See the BOM:524654 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Natural Capsules Ltd is an India-based company engaged in the manufacturing and selling of empty hard gelatin capsules. The products of the company are Hard gelatin capsule shells, Hard cellulose capsule shells, Shiny gelatin capsule shells, Sweet gelatin capsule shells, Enteric capsule shells, Printed gelatin capsule shells, Vegetarian capsule shells, Fortified gelatin capsule shells, and other capsules. It is also involved in formulating pharmaceutical dosage forms in capsule dosage form, both pharma and nutraceutical products.
46GF Score
Get the complete analysis for BOM:524654
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524654 has been successfully added to your 
